Article ID Journal Published Year Pages File Type
10761799 Biochemical and Biophysical Research Communications 2012 7 Pages PDF
Abstract
► Two cell-based reporter platforms were established for screening of EBNA1 inhibitors. ► EGCG acts as an inhibitor to block EBNA1 binding with the cognate oriP sequence. ► EGCG debilitates EBNA1-dependent transcription enhancement and episome maintenance. ► EGCG impairs persistence of EBV latency. ► EGCG is a potent anti-EBV agent for targeting the latent cascade of EBV.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , ,